FDA Warning Letter — Clarke Pharmaceutical Manufacturing, Inc.

Case 610642 — FEI 3010238039

The FDA took a Warning Letter action against Clarke Pharmaceutical Manufacturing, Inc. on February 2, 2021 (Webster, TX). The action was issued by CFSAN and concerns food/cosmetics products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Clarke Pharmaceutical Manufacturing, Inc.
Date
February 2, 2021
Fiscal Year
2021
Product Type
Food/Cosmetics
Center
CFSAN
Location
Webster, TX (United States)